Melosus

RSS

meloxicam

Authorised
This medicine is authorised for use in the European Union.

Overview

Melosus is an anti-inflammatory medicine used in dogs, cats and guinea pigs.

Dogs

In dogs, Melosus is used to lessen inflammation and pain in musculo-skeletal disorders.

Cats

In cats, Melosus is used to reduce pain and inflammation after orthopaedic and minor soft tissue surgery. Moreover, it is used to lessen pain and inflammation in chronic musculo-skeletal disorders.

Guinea pigs

In guinea pigs Melosus is used to reduce pain after soft tissue surgery such as castration.

Melosus contains the active substance meloxicam and is a ‘generic medicine’. This means that Melosus contains the same active substance and works in the same way as a ‘reference medicine’ already authorised in the European Union (EU) called Metacam.

This EPAR was last updated on 15/05/2019

Authorisation details

Product details
Name
Melosus
Agency product number
EMEA/V/C/002001
Active substance
meloxicam
International non-proprietary name (INN) or common name
meloxicam
Species
  • Dogs
  • Cats
  • Guinea pigs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AC06
GenericGeneric

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.

Publication details
Marketing-authorisation holder
CP-Pharma Handelsgesellschaft mbH
Revision
6
Date of issue of marketing authorisation valid throughout the European Union
21/02/2011
Contact address
Ostlandring 13
31303 Burgdorf
Germany

Product information

01/03/2019 Melosus - EMEA/V/C/002001 - IB/0007

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Musculoskeletal system

Therapeutic indication

Dogs:

  • Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.

Cats:

  • Alleviation of mild to moderate post-operative pain and inflammation following surgical procedures in cats, e.g. orthopaedic and soft tissue surgery.
  • Alleviation of pain and inflammation in chronic musculo-skeletal disorders in cats.

Guinea pigs:

  • Alleviation of mild to moderate post-operative pain associated with soft tissue surgery such as male castration.

Assessment history

How useful was this page?

Add your rating